0
30/06/2020
2020-06-30
false
false
false
false
false
false
false
false
false
false
true
false
false
true
false
false
false
false
false
false
false
No description of principal activities is disclosed
2019-07-01
Sage Accounts Production 20.0 - FRS102_2019
xbrli:pure
xbrli:shares
iso4217:GBP
02723336
2019-07-01
2020-06-30
02723336
2020-06-30
02723336
2019-06-30
02723336
bus:Director1
2019-07-01
2020-06-30
02723336
core:WithinOneYear
2020-06-30
02723336
core:WithinOneYear
2019-06-30
02723336
core:ShareCapital
2020-06-30
02723336
core:ShareCapital
2019-06-30
02723336
core:RetainedEarningsAccumulatedLosses
2020-06-30
02723336
core:RetainedEarningsAccumulatedLosses
2019-06-30
02723336
bus:SmallEntities
2019-07-01
2020-06-30
02723336
bus:AuditExempt-NoAccountantsReport
2019-07-01
2020-06-30
02723336
bus:FullAccounts
2019-07-01
2020-06-30
02723336
bus:SmallCompaniesRegimeForAccounts
2019-07-01
2020-06-30
02723336
bus:PrivateLimitedCompanyLtd
2019-07-01
2020-06-30
Company registration number:
02723336
Innovation Licensing Limited
Unaudited filleted financial statements
30 June 2020
Innovation Licensing Limited
Contents
Statement of financial position
Notes to the financial statements
Innovation Licensing Limited
Statement of financial position
30 June 2020
|
|
|
2020 |
|
|
|
2019 |
|
|
|
|
Note |
£ |
|
£ |
|
£ |
|
£ |
|
|
|
|
|
|
|
|
|
|
|
Current assets |
|
|
|
|
|
|
|
|
|
|
Debtors |
|
4 |
124 |
|
|
|
3,645 |
|
|
|
Cash at bank and in hand |
|
|
2,051 |
|
|
|
2,636 |
|
|
|
|
|
_______ |
|
|
|
_______ |
|
|
|
|
|
2,175 |
|
|
|
6,281 |
|
|
|
Creditors: amounts falling due |
|
|
|
|
|
|
|
|
|
|
within one year |
|
5 |
(
57,463) |
|
|
|
(
58,056) |
|
|
|
|
|
_______ |
|
|
|
_______ |
|
|
|
Net current liabilities |
|
|
|
|
(
55,288) |
|
|
|
(
51,775) |
|
|
|
|
|
_______ |
|
|
|
_______ |
|
Total assets less current liabilities |
|
|
|
|
(
55,288) |
|
|
|
(
51,775) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
_______ |
|
|
|
_______ |
|
Net liabilities |
|
|
|
|
(
55,288) |
|
|
|
(
51,775) |
|
|
|
|
|
_______ |
|
|
|
_______ |
|
|
|
|
|
|
|
|
|
|
|
Capital and reserves |
|
|
|
|
|
|
|
|
|
|
Called up share capital |
|
|
|
|
2 |
|
|
|
2 |
|
Profit and loss account |
|
|
|
|
(
55,290) |
|
|
|
(
51,777) |
|
|
|
|
|
_______ |
|
|
|
_______ |
|
Shareholders deficit |
|
|
|
|
(
55,288) |
|
|
|
(
51,775) |
|
|
|
|
|
_______ |
|
|
|
_______ |
|
|
|
|
|
|
|
|
|
|
For the year ending 30 June 2020 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
-
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
-
The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
These financial statements were approved by the
board of directors
and authorised for issue on
24 February 2021
, and are signed on behalf of the board by:
C Costa
Director
Company registration number:
02723336
Innovation Licensing Limited
Notes to the financial statements
Year ended 30 June 2020
1.
General information
The company is a private company limited by shares, registered in England. The address of the registered office is 23 Princes Street, London, W1B 2LX.
2.
Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'. The Triennial review 2017 amendments to the standard have been early adopted.
3.
Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4.
Debtors
|
|
|
2020 |
2019 |
|
|
|
£ |
£ |
|
Trade debtors |
|
- |
3,590 |
|
Other debtors |
|
124 |
55 |
|
|
|
_______ |
_______ |
|
|
|
124 |
3,645 |
|
|
|
_______ |
_______ |
|
|
|
|
|
5.
Creditors: amounts falling due within one year
|
|
|
2020 |
2019 |
|
|
|
£ |
£ |
|
Other creditors |
|
57,463 |
58,056 |
|
|
|
_______ |
_______ |
|
|
|
|
|
6.
Related party transactions
At the balance sheet date the company owed
C Costa
, a director and shareholder, £56,663 (2019: £57,256). The loan was unsecured and interest free.
7.
Going Concern
The company is reliant on the continued support of its director. At the balance sheet date the directors knows of no reason why this will not continue.
